Oncolytics Biotech ONCY
NASDAQ ONCY
$0.51 0.00 (-0.35%)
As of: Oct 22, 2026 · 11:53 AM EDT

Oncolytics Biotech (ONCY) Other Non-Current Assets (2009 - 2011)

Updated

Oncolytics Biotech (ONCY) recorded Other Non-Current Assets of $14.87 million in Q4 2018.

Analysis

Oncolytics Biotech (ONCY) Other Non-Current Assets (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 14.27 Bn
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn 10.73 Bn
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn -
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn 4.75 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 9.94 Bn
10 Oncolytics Biotech 60.96 Mn 32.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 735,681.00
Mar 31, 2011 735,681.00
Dec 31, 2010 735,681.00
Dec 31, 2009 684,000.00
API Access

Oncolytics Biotech Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ONCY&period=max&api_key=YOUR_API_KEY